<DOC>
	<DOCNO>NCT01910649</DOCNO>
	<brief_summary>The purpose extension phase study determine whether Drisapersen effective treatment boy Duchenne muscular dystrophy result mutation think correct exon 51 skipping .</brief_summary>
	<brief_title>A Phase I/II , Open Label , Escalating Dose , Pilot Study Assess Effect , Safety , Tolerability PK Multiple SC Doses Drisapersen Patients With Duchenne Muscular Dystrophy Assess Potential IV Dosing Alternative Route Administration</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Boys age 5 16 year inclusive . Duchenne muscular dystrophy result mutation correctable treatment PRO051 . Not ventilator dependent . Life expectancy least six month . No previous treatment investigational medicinal treatment within six month prior study . Willing able adhere study visit schedule protocol requirement . Aberrant RNA splice and/or aberrant response PRO051 , detect vitro PRO051 assay screening . Known presence dystrophin 5 % fiber prestudy diagnostic muscle biopsy . Severe muscle abnormality define increased signal intensity &gt; 50 % tibialis anterior muscle MRI . FEV1 and/or FVC &lt; 60 % predict . Current history liver renal disease . Acute illness within 4 week prior treatment ( Day 1 ) may interfere measurement . Severe mental retardation opinion investigator prohibit participation study . Severe cardiac myopathy opinion investigator prohibit participation study . Need mechanical ventilation . Creatinine concentration 1.5 time upper limit normal ( age correct ) . Serum ASAT and/or ALAT concentration ( ) suggest hepatic impairment . Use anticoagulant , antithrombotics antiplatelet agent . Subject donate blood le 90 day start study . Current history drug and/or alcohol abuse . Participation another trial investigational product .</criteria>
	<gender>Male</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>drisapersen</keyword>
</DOC>